<DOC>
	<DOCNO>NCT01541098</DOCNO>
	<brief_summary>This multi center , phase 2 randomize control study determine effect lyophilize plasma patient warfarin therapy .</brief_summary>
	<brief_title>A Clinical Study Lyophilized Plasma Patients Warfarin</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion Criteria 1 . Patients receive oral anticoagulation warfarin derive agent . 2 . Patients need urgent surgery , invasive procedure identification patient active bleed oral parenteral vitamin K therapy deem slow action reversal warfarin anticoagulant effect . 3 . Patients elevate international normalized ratio . Exclusion Criteria 1 . Patients clinically unstable . 2 . Patients congenital acquire coagulopathies ( warfarin therapy ) . 3 . Patients receive medication could interfere result laboratory test . 4 . Pregnant nursing woman . 5 . Patients participate another clinical treatment study currently past 1 month prior study inclusion . 6 . Patients previously enrol study . 7 . Active illicit drug use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>